4//SEC Filing
Rubin Eyal 4
Accession 0001104659-22-028159
CIK 0001006281other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:02 PM ET
Size
5.4 KB
Accession
0001104659-22-028159
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Common Stock
2022-02-25+121,951→ 368,097 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001721411
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:02 PM ET
- Size
- 5.4 KB